BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation
2061 – 2070 of 3090
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Reduced expression of ezrin in urothelial bladder cancer signifies more advanced tumours and an impaired survival: validatory study of two independent patient cohorts.
(
- Contribution to journal › Article
-
Mark
Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.
(
- Contribution to journal › Article
-
Mark
Reduced expression of the polymeric immunoglobulin receptor in pancreatic and periampullary adenocarcinoma signifies tumour progression and poor prognosis
(
- Contribution to journal › Article
-
Mark
Deregulation of COMMD1 Is Associated with Poor Prognosis in Diffuse Large B-cell Lymphoma.
(
- Contribution to journal › Article
-
Mark
High dose cytarabine with rituximab is not enough in first-line treatment of mantle cell lymphoma with high proliferation: early closure of the Nordic Lymphoma Group Mantle Cell Lymphoma 5 trial
(
- Contribution to journal › Letter
-
Mark
Treatment outcome in T-cell lymphoblastic lymphoma in adults - a population-based study from the Swedish Lymphoma Registry
(
- Contribution to journal › Article
-
Mark
Heterogenous mismatch-repair status in colorectal cancer
(
- Contribution to journal › Article
-
Mark
Canceröverlevnaden på väg uppåt i Danmark efter 3-punktsplan Snabb utredning vid misstänkt cancersjukdom är en grund.
(
- Contribution to journal › Article
-
Mark
Csnk1a1 inhibition has p53-dependent therapeutic efficacy in acute myeloid leukemia
(
- Contribution to journal › Article
-
Mark
Increased health care utilization by survivors of childhood lymphoblastic leukemia is confined to those treated with cranial or total body irradiation: a case cohort study.
(
- Contribution to journal › Article